Dr. John Engelhardt is a prominent researcher and academician with a vast experience of studying inherited and environmentally induced diseases. He is currently serving as the Professor and Chair of the Department of Anatomy and Cell Biology and the Roy J. Carver Chair in Molecular Medicine at the University of Iowa Carver College of Medicine. His research primarily focuses on the development of animal models to understand the molecular basis of genetic diseases and to devise gene therapies for the same. Dr. Engelhardt leads the P30 Center for Gene Therapy of Cystic Fibrosis and has received continuous funding from NIDDK for the last 21 years.

Dr. Engelhardt's notable contributions include the study of the pathogenesis of cystic fibrosis and diabetes, the development of larger animal models of lung diseases using genome-editing technologies and somatic cell nuclear transfer, and clinical trials to evaluate cystic fibrosis-related diabetes in infants and children. Additionally, his group is investigating beta-cell function and how it relates to the CF ferret model. Dr. Engelhardt's research has resulted in several publications in prestigious journals, and he has an H-index of 93 and over 29,500 citations till January 2021.

Overall, Dr. John Engelhardt is an accomplished academic and researcher with specific expertise in animal models, molecular medicine, and gene therapy.